These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

444 related articles for article (PubMed ID: 28624477)

  • 1. Nanoformulations for combination or cascade anticancer therapy.
    Miao L; Guo S; Lin CM; Liu Q; Huang L
    Adv Drug Deliv Rev; 2017 Jun; 115():3-22. PubMed ID: 28624477
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nanoformulation-based sequential combination cancer therapy.
    Shim G; Kim MG; Kim D; Park JY; Oh YK
    Adv Drug Deliv Rev; 2017 Jun; 115():57-81. PubMed ID: 28412324
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nanomedicine-based combination anticancer therapy between nucleic acids and small-molecular drugs.
    Huang W; Chen L; Kang L; Jin M; Sun P; Xin X; Gao Z; Bae YH
    Adv Drug Deliv Rev; 2017 Jun; 115():82-97. PubMed ID: 28624478
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Simultaneous delivery of doxorubicin and GG918 (Elacridar) by new polymer-lipid hybrid nanoparticles (PLN) for enhanced treatment of multidrug-resistant breast cancer.
    Wong HL; Bendayan R; Rauth AM; Wu XY
    J Control Release; 2006 Dec; 116(3):275-84. PubMed ID: 17097178
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lipid-coated polymeric nanoparticles for cancer drug delivery.
    Krishnamurthy S; Vaiyapuri R; Zhang L; Chan JM
    Biomater Sci; 2015 Jul; 3(7):923-36. PubMed ID: 26221931
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Comprehensive Review on Role of Nanoparticles in Therapeutic Delivery of Medicine.
    Rathor S; Bhatt DC; Aamir S; Singh SK; Kumar V
    Pharm Nanotechnol; 2017; 5(4):263-275. PubMed ID: 29141578
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Classification of stimuli-responsive polymers as anticancer drug delivery systems.
    Taghizadeh B; Taranejoo S; Monemian SA; Salehi Moghaddam Z; Daliri K; Derakhshankhah H; Derakhshani Z
    Drug Deliv; 2015 Feb; 22(2):145-55. PubMed ID: 24547737
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Editorial of Special Issue "Surface-Functionalized Nanoparticles as Drug Carriers".
    Layek B; Singh J
    Int J Mol Sci; 2019 Dec; 20(24):. PubMed ID: 31861113
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vitamin E TPGS-emulsified poly(lactic-co-glycolic acid) nanoparticles for cardiovascular restenosis treatment.
    Feng SS; Zeng W; Teng Lim Y; Zhao L; Yin Win K; Oakley R; Hin Teoh S; Hang Lee RC; Pan S
    Nanomedicine (Lond); 2007 Jun; 2(3):333-44. PubMed ID: 17716178
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Construction and comparison of different nanocarriers for co-delivery of cisplatin and curcumin: A synergistic combination nanotherapy for cervical cancer.
    Li C; Ge X; Wang L
    Biomed Pharmacother; 2017 Feb; 86():628-636. PubMed ID: 28027539
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High loading fragrance encapsulation based on a polymer-blend: preparation and release behavior.
    Sansukcharearnpon A; Wanichwecharungruang S; Leepipatpaiboon N; Kerdcharoen T; Arayachukeat S
    Int J Pharm; 2010 May; 391(1-2):267-73. PubMed ID: 20170720
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Polymer nanoparticles for the intravenous delivery of anticancer drugs: the checkpoints on the road from the synthesis to clinical translation.
    Ferrari R; Sponchioni M; Morbidelli M; Moscatelli D
    Nanoscale; 2018 Dec; 10(48):22701-22719. PubMed ID: 30512025
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nanogel--an advanced drug delivery tool: Current and future.
    Sharma A; Garg T; Aman A; Panchal K; Sharma R; Kumar S; Markandeywar T
    Artif Cells Nanomed Biotechnol; 2016; 44(1):165-77. PubMed ID: 25053442
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lipid polymer hybrid as emerging tool in nanocarriers for oral drug delivery.
    Hallan SS; Kaur P; Kaur V; Mishra N; Vaidya B
    Artif Cells Nanomed Biotechnol; 2016; 44(1):334-49. PubMed ID: 25237838
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of drug solubility and lipid carrier on drug release from lipid nanoparticles for dermal delivery.
    Zoubari G; Staufenbiel S; Volz P; Alexiev U; Bodmeier R
    Eur J Pharm Biopharm; 2017 Jan; 110():39-46. PubMed ID: 27810471
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effective combination therapy against human osteosarcoma: doxorubicin plus curcumin co-encapsulated lipid-coated polymeric nanoparticulate drug delivery system.
    Wang L; Wang W; Rui Z; Zhou D
    Drug Deliv; 2016 Nov; 23(9):3200-3208. PubMed ID: 26987435
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development and in vitro characterization of chitosan-coated polymeric nanoparticles for oral delivery and sustained release of the immunosuppressant drug mycophenolate mofetil.
    Mohammed M; Mansell H; Shoker A; Wasan KM; Wasan EK
    Drug Dev Ind Pharm; 2019 Jan; 45(1):76-87. PubMed ID: 30169982
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relevance of Nanotechnology in Solving Oral Drug Delivery Challenges: A Perspective Review.
    Dhadde SB; Patil JS; Chandakavathe BN; Thippeswamy BS; Kavatekar MG
    Crit Rev Ther Drug Carrier Syst; 2020; 37(5):407-434. PubMed ID: 33389846
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy.
    Pérez-Herrero E; Fernández-Medarde A
    Eur J Pharm Biopharm; 2015 Jun; 93():52-79. PubMed ID: 25813885
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Design of nanocarriers for nanoscale drug delivery to enhance cancer treatment using hybrid polymer and lipid building blocks.
    Zhang RX; Ahmed T; Li LY; Li J; Abbasi AZ; Wu XY
    Nanoscale; 2017 Jan; 9(4):1334-1355. PubMed ID: 27973629
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.